Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 28;15(1):18760.
doi: 10.1038/s41598-025-04024-1.

Serum alpha-klotho levels associate with bone mineral density in chronic kidney disease patients from NHANES 2011 to 2016

Affiliations

Serum alpha-klotho levels associate with bone mineral density in chronic kidney disease patients from NHANES 2011 to 2016

Yani Zhang et al. Sci Rep. .

Abstract

This study investigated the relationship between serum Alpha-Klotho (α-Klotho) levels and bone mineral density (BMD) in patients with chronic kidney disease (CKD) using data from the National Health and Nutrition Examination Survey (NHANES) 2011-2016. A population of 781 CKD patients aged ≥ 40 years was analyzed using multiple linear regression models to examine the association between serum α-Klotho levels and BMD at different skeletal sites, with adjustments for demographic, lifestyle, and clinical factors. Results showed that serum α-Klotho levels were significantly correlated with BMD at thoracic spine (β = 0.004 g/cm2, p = 0.00264), total BMD (β = 0.003 g/cm2, p = 0.02591), and trunk BMD (β = 0.002 g/cm2, p = 0.03708), while no significant associations were observed at the left leg, lumbar spine, or pelvis. Stratified analyses showed that the association was more pronounced in men, non-Hispanic whites, those with a body mass index greater than 29.9 kg/m2, and those without hypertension and diabetes. The inconsistent associations observed across different skeletal sites suggest that it remains unclear whether serum α-Klotho levels are consistently associated with BMD in CKD patients. Additionally, the cross-sectional design precludes any determination of causality in the observed site-specific associations.

Keywords: Alpha-Klotho; Bone mineral density; Chronic kidney disease; NHANES.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The survey protocol was approved by the NCHS Institutional Review Board, before conducting the survey, and all participants provided informed consent in their own name or a legally authorized representative. All methods were performed in accordance with the relevant guidelines and regulations of the NCHS Institutional Review Board. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Participant Selection Flowchart for the Study Cohort. This study began with 29,902 participants from the NAHANSE 2011–2016 survey and sequentially excluded participants who did not meet the participants who did not meet the inclusion criteria. CKD was defined using KDIGO guideline criteria and calculated by the CKD-EPI formula.
Fig. 2
Fig. 2
Correlation of serum α-klotho/100 levels with site-specific BMD. Analyzing linear and nonlinear relationships between α-Klotho and BMD using generalized additive models. The solid red line represents the smooth curve fit between variables. Blue bands represent the 95% confidence interval of the fit. Race, gender, age, education, income poverty ratio, alcohol, smoking, ALP, AST, ALT, total calcium, creatinine, globulin, phosphorus, hypertension, BMI, HGB, PLT, Hba1c, physical activity, dietary vitamin D, dietary calcium and 25(OH)vitamin D were adjusted.

Similar articles

References

    1. Dong, B. et al. Epidemiological analysis of chronic kidney disease from 1990 to 2019 and predictions to 2030 by Bayesian age-period-cohort analysis. Ren. Fail. ;46(2):2403645. doi: 10.1080/0886022X.2024.2403645. (2024). Epub 2024 Sep 19. - PMC - PubMed
    1. Johnson, H. N. & Prasad-Reddy, L. Updates in chronic kidney disease. J. Pharm. Pract.37 (6), 1380–1390. 10.1177/08971900241262381 (2024). Epub 2024 Jun 14. - PubMed
    1. Florea, A. et al. Chronic kidney disease unawareness and determinants using 1999–2014 National health and nutrition examination survey data. J. Public. Health (Oxf). 44 (3), 532–540. 10.1093/pubmed/fdab112 (2022). - PMC - PubMed
    1. Lloret, M. J. et al. Evaluating osteoporosis in chronic kidney disease: Both bone quantity and quality matter. J. Clin. Med.13 (4), 1010. 10.3390/jcm13041010 (2024). - PMC - PubMed
    1. Hsu, C. Y., Chen, L. R. & Chen, K. H. Osteoporosis in patients with chronic kidney diseases: A systemic review. Int. J. Mol. Sci.21 (18), 6846. 10.3390/ijms21186846 (2020). - PMC - PubMed

LinkOut - more resources